PPAR-γ对动脉粥样硬化中单核/巨噬细胞的作用
摘要
过氧化物酶体增殖激活受体γ(peroxisome proliferafors-activated receptor gamma PPARγ)是核受体超家族成员之一,参与体内多种生理病理过程,近年来研究表明,该类受体激活后还可以对动脉动脉粥样硬化病变所涉及的病理途径进行调节。目前其对血管局部单核/巨噬细胞的调节作用仍存在许多争议之处,其激活剂可能对动脉粥样硬化的防治具有重要意义。
出处
《中国分子心脏病学杂志》
CAS
2007年第1期47-50,共4页
Molecular Cardiology of China
参考文献24
-
1[1]Issemann I,Green S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.Nature,1990,347(6294):645-650.
-
2[2]Nagy L,Tontonoz P,Alvarez JG,et al.Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma.Cell,1998,93(2):229-240.
-
3[3]Neve BP,Fruchart JC,Staels B.Role of the peroxisome proliferators-activated receptors (PPAR) in atherosclerosis.Biochem Pharmacol,2000,60(8):1245-1250.
-
4[4]Pasceri V,Cheng JS,Willerson JT,et al.Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.Circulation,2001,103(21):2531-2534.
-
5[5]Han KH,Chang MK,Boullier A,et al.Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferators-activated receptor gamma.J Clin Invest,2000,106 (6):793 -802.
-
6[6]Goetze S,Eilers F,Bungenstock A,et al.PPAR activators inhibit endothelial cell migration by targeting AKt.Biochem Biophys Res Commun,2002,293 (5):1431-1437.
-
7[7]Takata Y,Kitami Y,Yang ZH,et al.Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-bind-ingprotein-delta and peroxisome proliferators-activated preceptor-gamma.Circ Res,2002,91(5):427-433.
-
8[8]Chinetti G,Griglio S,Antonucci M,et al.Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.J Biol Chem,1998,273 (40):25575-25580.
-
9[9]Marx N,Sukhova G,Murphy C,et al.Macrophages in human atheroma contain PPAR gamma:differentiation-dependent peroxisomal proliferator-activated preceptor-gamma (PPAR gamma) expression and reduction of MMP-9 activity through PPAR gamma activation in mononuclear phagocytes in vitro.Am J Pathol,1998,153 (1):17-23.
-
10[10]Moore KJ,Rosen ED,Fitzgerald ML,et al.The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.Nat Med,2001,7(1):41-47.
二级参考文献29
-
1[1]Freeman, M.W, Ekkel, Y., Rohrer, L,et al.Expression of type Ⅰ and type Ⅱ bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.Proc Natl.Acad.Sci,1991,88:4931- 4935
-
2[2]Kunjathoor VV, Febbraio M,Podrez EA.Scavenger receptors class A-Ⅰ/Ⅱ and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.J Biol Chem,2002, Dec 20;277 (51):49982- 49988
-
3[3]Reaven EL, Zhan A, Nomoto A, et al.Expression and microvillar localization of scavenger receptor class B, type I (SR-BⅠ) and selective cholesteryl ester uptake in Leydig cells from rat testis.J Lipid Res,2000,Mar;41(3):343-356
-
4[4]Resnick, D,Chatterton, JE,Schwartz, K,et al.Structures of class A macrophage scavenger receptors.Electron microscopic study of flexible, multidomain, fibrous proteins and determination of the disulfide bond pattern of the scavenger receptor cysteine-rich domain.J.Biol.Chem,1996,271: 26924-26930
-
5[5]Ninetta K, Stuart R, Alan D,et al.Class A Scavenger Receptor-mediated Adhesion and Internalization Require Distinct Cytoplasmic Domains.J Biol Chem,2003,278(36),34219-34225
-
6[6]Boullier A, Bird DA, Chang MK, et al.Scavenger receptors, oxidized LDL, and atherosclerosis.Ann N Y Acad Sci,2001,Dec;947:214-222.
-
7[7]Hsu H.Y, Hajjar D.P, Khan K.M,et al.Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway.J Biol Chem,1998, 273:1240-1246
-
8[8]Sakai M, Kobori S, Miyazaki A,et al.Macrophage proliferation in atherosclerosis.Curr Opin Lipidol,2000,Oct;11(5):503-509
-
9[9]Ishibashi, S, T.Inaba, H.Shimano, et al.Colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in humanderived macrophages.J.Biol Chem,1990,265:14109-14117
-
10[10]Van Lenten, B.J, and A.M.Fogelman.Lipopolysac-charide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factora.J.Immunol,1992,148:112-116
共引文献6
-
1谭俊,王丽丽.动脉粥样硬化中脂质储运、外流模式及其调节[J].心血管病学进展,2006,27(z1):98-102.
-
2张玲,张文高,王怡斐.中药通过清道夫受体干预动脉粥样硬化的研究进展[J].中西医结合心脑血管病杂志,2009,7(2):197-199. 被引量:1
-
3俞宁娟,倪海祥.2型糖尿病患者单核巨噬细胞PPARγ的mRNA表达及人参皂苷对其表达的影响[J].实用糖尿病杂志,2009,5(1):32-34. 被引量:5
-
4韩露,修宗谊,张继倬.罗格列酮减轻大鼠自体颈静脉移植后内膜增生[J].中国动脉硬化杂志,2010,18(8):633-635.
-
5谭志辉,张先林.胆固醇结石形成的相关性因素研究[J].中国普外基础与临床杂志,2016,23(1):123-126. 被引量:7
-
6张可依,干伟.SR-BⅠ基因多态性与高密度脂蛋白代谢和冠心病发病关系的研究进展[J].检验医学与临床,2018,15(15):2346-2350.
-
1秦玲,雷宇,张尉华,陈爱军,黄可心,刘丽辉.动脉粥样硬化病变中过氧化物酶体增殖激活受体γ的表达[J].吉林大学学报(医学版),2006,32(1):43-46. 被引量:4
-
2彭城,李东野.急性冠状动脉综合征患者外周血单核细胞过氧化物酶体增殖物激活受体γ的表达及意义[J].现代医学,2012,40(2):171-174.
-
3靳广,魏枫.PPARγ激动剂罗格列酮钠对2型糖尿病大鼠肾保护作用的实验研究[J].中国临床研究,2010,23(10):845-846. 被引量:2
-
4张莉,杨永健.过氧化物酶体增殖物激活受体γ抗动脉粥样硬化研究进展[J].中国心血管杂志,2012,17(1):76-78. 被引量:4
-
5肖敏,朱涛,汪涛,文富强.甘草酸二铵抑制慢性哮喘模型小鼠气道平滑肌增生[J].南方医科大学学报,2013,33(10):1416-1420. 被引量:5
-
6田小飞,马玮娟,张键.脂肪因子Chemerin与非酒精性脂肪肝病的关系[J].公共卫生与预防医学,2015,26(2):75-78. 被引量:4
-
7江颖,邹琳,张春晖,陆维祺,朱隽,罗文杰,张华,沈爱国.乳腺癌中过氧化物酶体增殖激活受体γ和β-连环蛋白表达及临床意义[J].中华实验外科杂志,2010,27(6):699-701. 被引量:4
-
8叶宽萍,王少华,孙子林,黄艳.大鼠PPARγ shRNA慢病毒载体的构建与鉴定[J].江苏医药,2011,37(13):1528-1531.
-
9许海波,巩鹏.PPARs在梗阻性黄疸肝脏损伤中的作用[J].国际外科学杂志,2007,34(7):461-465. 被引量:3
-
10关晶,曲竹秋,王莎莎.速效救心丸对动脉粥样硬化大鼠干预作用的实验研究[J].天津中医药,2009,26(6):486-488. 被引量:6